James Micro Cap Fund
JMCRX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1349 Fairground Rd Beavercreek OH United States of America 45385
- IPO Date
- Jul 7, 2010
- CIK
- 0001045487
- Website
- jamesinvestment.com
- Similar Companies
- Business
- James Micro Cap Fund (JMCRX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in equity securities of domestic and foreign micro-capitalization companies deemed undervalued by its adviser, including common stocks, preferred stocks, and exchange-traded funds focused on such securities; under normal circumstances, it allocates at least 80% of net assets plus any investment borrowings to micro-cap equities defined by market capitalizations no larger than those in the VettaFi US Equity Micro-Cap TR Index. The fund maintains a diversified portfolio of approximately 75 stocks with a median capitalization of $1.34 billion, emphasizing quality core holdings with a value tilt across sectors led by financials (32.5%), information technology (16.3%), industrials (12.2%), health care (11.7%), and consumer discretionary (8.2%), with top holdings including Nova Ltd, Enova International Inc, Piper Sandler Companies, Federal Agricultural Mortgage Corp, and OFG Bancorp. Managed by a team comprising R. Brian Culpepper (President and CEO), Brian P. Shepardson (Vice President), and Trent D. Dysert (Assistant Vice President), it features a net expense ratio of 1.50%, including a 1.46% management fee, and targets aggressive equity investors with extended horizons. Launched on July 1, 2010, and domiciled in the United States, the fund is advised by James Investment Research, Inc., headquartered in Alpha, Ohio, with total net assets of approximately $26.9 million as of June 30, 2025, and shares available through U.S. brokers with a minimum initial investment of $10,000. It operates within the small value category per Morningstar, holding a three-star overall rating (out of 477 funds) as of mid-2025, with allocations heavily weighted toward U.S. equities (around 97%, including cash at 3.2%) and market cap exposure primarily under $6 billion. The fund distributes income, short-term capital gains, and long-term capital gains annually, with recent payouts including $0.2643 long-term and $0.0423 short-term per share in December 2024. Recent developments include sustained portfolio management stability with no reported portfolio manager changes since Trent Dysert joined in 2014, alongside consistent annual capital gains distributions through 2025 and updated fact sheets reflecting asset levels and performance through June 30, 2025, amid ongoing proprietary research-driven adjustments to undervalued micro-cap selections in a volatile small-cap environment. No major acquisitions, funding rounds, strategic alliances, or product launches were noted in the past 1-2 years, with focus remaining on disciplined equity selection for long-term growth. As of late 2025, assets under management hovered around $26 million, with year-to-date returns at approximately 6.91% through December 2025.